The Construction of Primary Screening Model and Discriminant Model for Chronic Obstructive Pulmonary Disease in Northeast China

References

• WangC, XuJ, YangL, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10313):1706–1717. doi:10.1016/S0140-6736(18)30841-929650248
   PubMed Web of Science ®Google Scholar
• ZhouY, ZhongNS, LiX, et al. Tiotropium in early-stage chronic obstructive pulmonary disease. N Engl J Med. 2017;377(10):923–935. doi:10.1056/NEJMoa170022828877027
   PubMed Web of Science ®Google Scholar
• DilektasliAG, PorszaszJ, CasaburiR, et al. A novel spirometric measure identifies mild COPD unidentified by standard criteria. Chest. 2016;150(5):1080–1090. doi:10.1016/j.chest.2016.06.04727452770
   PubMed Web of Science ®Google Scholar
• MirsadraeeM, BoskabadyMH, AttaranD. Diagnosis of chronic obstructive pulmonary disease earlier than current Global initiative for obstructive lung disease guidelines using a feasible spirometry parameter (maximal-mid expiratory flow/forced vital capacity). Chron Respir Dis. 2013;10(4):191–196. doi:10.1177/147997231350746124177680
   PubMed Web of Science ®Google Scholar
• Caubet FernandezM, DrouinS, SamoilenkoM, et al. A Bayesian multivariate latent t-regression model for assessing the association between corticosteroid and cranial radiation exposures and cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia: a PETALE study. BMC Med Res Methodol. 2019;19(1):100. doi:10.1186/s12874-019-0725-931088361
   PubMed Web of Science ®Google Scholar
• VavougiosGD, DoskasT, KonstantopoulosK. An electroglottographical analysis-based discriminant function model differentiating multiple sclerosis patients from healthy controls. Neurol Sci. 2018;39(5):847–850. doi:10.1007/s10072-018-3267-829450761
   PubMed Web of Science ®Google Scholar
• International Primary Care Airway Group. Ipag diagnosis management handbook–chronic airways disease. A guide for primarycarephysician[M/OL]. (2005—1)[2009-3—15] Available from: http://www.ipagguide.org.
   Google Scholar
• LevyML, FletcherM, PriceDB, et al. International Primary Care Respiratory Group (IPCRG) guidelines: diagnosis of respiratory diseases in primary care. Prim Care Respir J. 2006;15:20–34.16701756
   PubMedGoogle Scholar
• JonesPW, QuirkFH, BaveystockCM, LittlejohnsP. A self-complete measure of health status for chronic airflow limitation. The St. George’s respiratory questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.13211595997
   PubMed Web of Science ®Google Scholar
• FletcherCM. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ. 1960;2:1662.
   Google Scholar
• JonesPW, HardingG, BerryP, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.0010250919720809
   PubMed Web of Science ®Google Scholar
• MillerMR, HankinsonJ, BrusascoV, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.0003480516055882
   PubMed Web of Science ®Google Scholar
• for the PROBAST Group†; WolffRF, MoonsKG, RileyRD, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170(1):51–58. doi:10.7326/M18-1376.30596875
   PubMed Web of Science ®Google Scholar
• McCloskeySC, PatelBD, HinchliffeSJ, ReidED, WarehamNJ, LomasDA. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med. 2001;164(8):1419–1424. doi:10.1164/ajrccm.164.8.210500211704589
   PubMed Web of Science ®Google Scholar
• DingZ, WangK, LiJ, TanQ, TanW, GuoG. Association between glutathione S-transferase gene M1 and T1 polymorphisms and chronic obstructive pulmonary disease risk: a meta-analysis. Clin Genet. 2018;95(1):53–62. doi:10.1111/cge.1337329704242
   PubMed Web of Science ®Google Scholar
• TagerIB, NgoL, HanrahanJP. Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. Am J Respir Crit Care Med. 1995;152(3):977–983. doi:10.1164/ajrccm.152.3.76638137663813
   PubMed Web of Science ®Google Scholar
• BarkerDJ, GodfreyKM, FallC, OsmondC, WinterPD, ShaheenSO. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ. 1991;303(6804):671–675. doi:10.1136/bmj.303.6804.6711912913
   PubMed Web of Science ®Google Scholar
• TodiscoT, de BenedictisFM, IannacciL, et al. Mild prematurity and respiratory functions. Eur J Pediatr. 1993;152(1):55–58. doi:10.1007/BF20725178444206
   PubMed Web of Science ®Google Scholar
• HarikkhanRI, FlegJL, WiseRA. Body mass index and the risk of COPD. Chest. 2002;121(2):370–376. doi:10.1378/chest.121.2.37011834645
   PubMed Web of Science ®Google Scholar
• LiuY, PleasantsRA, CroftJB, et al. Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease. Respir Med. 2015;109(7):851–859. doi:10.1016/j.rmed.2015.05.00626006753
   PubMed Web of Science ®Google Scholar
• GuoY, ZhangT, WangZ, et al. Body mass index and mortality in chronic obstructive pulmonary disease: a dose-response meta-analysis. Medicine (Baltimore). 2016;95(28):e4225. doi:10.1097/MD.000000000000422527428228
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJ, FarreroE, FélezMA, IzquierdoJ, MarradesRM, AntóJM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100–105. doi:10.1136/thorax.58.2.10012554887
   PubMed Web of Science ®Google Scholar
• ZafariZ, SinDD, PostmaDS, et al. Individualized prediction of lung-function decline in chronic obstructive pulmonary disease. Can Med Assoc J. 2016;188(14):1004–1011. doi:10.1503/cmaj.15148327486205
   PubMed Web of Science ®Google Scholar
• SuKC, KoHK, ChouKT, et al. An accurate prediction model to identify undiagnosed at-risk patients with COPD: a cross-sectional case-finding study. NPJ Prim Care Respir Med. 2019;29(1):22. doi:10.1038/s41533-019-0135-931138809
   PubMed Web of Science ®Google Scholar
• ChenW, SinDD, FitzGeraldJM, SafariA, AdibiA, SadatsafaviM. An individualized prediction model for long-term lung function trajectory and risk of COPD in the general population. Chest. 2019;157(3):547–557.31542453
   PubMed Web of Science ®Google Scholar
• CuiJ1, ZhouY, TianJ, et al. A discriminant function model as an alternative method to spirometry for COPD screening in primary care settings in China. J Thorac Dis. 2012;4(6):594–600. doi:10.3978/j.issn.2072-1439.2012.11.0623205284
   PubMed Web of Science ®Google Scholar
• MelanieM, GayanB, JenniferP, et al. Prediction models for the development of COPD: a systematic review. Int J Chron Obstruct Pulmon Dis. 2018;13:1927–1935. doi:10.2147/COPD.S15567529942125
   PubMed Web of Science ®Google Scholar
• GuerraB, GaveikaiteV, BianchiC, PuhanMA. Prediction models for exacerbations in patients with COPD. Eur Respir Rev. 2017;26(143):pii:160061. doi:10.1183/16000617.0061-2016
   PubMed Web of Science ®Google Scholar